Schmidt-Kraepelin, C., Feyerabend, S., Engelke, C., Riesbeck, M., Meisenzahl-Lechner, E., Verde, P., . . . Cordes, J. (2022). Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): A double-blind randomised controlled trial. The lancet. Psychiatry, 9(4), . https://doi.org/10.1016/S2215-0366(22)00032-3
Chicago-Zitierstil (17. Ausg.)Schmidt-Kraepelin, Christian, et al. "Amisulpride and Olanzapine Combination Treatment Versus Each Monotherapy in Acutely Ill Patients with Schizophrenia in Germany (COMBINE): A Double-blind Randomised Controlled Trial." The Lancet. Psychiatry 9, no. 4 (2022). https://doi.org/10.1016/S2215-0366(22)00032-3.
MLA-Zitierstil (9. Ausg.)Schmidt-Kraepelin, Christian, et al. "Amisulpride and Olanzapine Combination Treatment Versus Each Monotherapy in Acutely Ill Patients with Schizophrenia in Germany (COMBINE): A Double-blind Randomised Controlled Trial." The Lancet. Psychiatry, vol. 9, no. 4, 2022, https://doi.org/10.1016/S2215-0366(22)00032-3.